Dr. Shaf Keshavjee, MD MSc
Claim this profileToronto General Hospital, University Health Network
Studies Lung Transplant
Studies ABO Blood Group Incompatibility
2 reported clinical trials
1 drug studied
Affiliated Hospitals
Clinical Trials Shaf Keshavjee, MD MSc is currently running
A2 Donor Lungs
for O Recipient Transplant
Blood group A2 to blood group O kidney and liver transplants have been shown to be safe and successful, especially in recipients with low pre-operative anti-A antibody titers and with the use of peri-operative antibody-depleting therapies. Since blood group O lung transplant candidates tend to have longer wait times and a higher waitlist mortality compared to other blood groups, we propose to conduct a prospective study of lung transplantation from blood group A2 donors to eligible blood group O recipients in an effort to increase the available donor pool. The aim of this study is to determine both the feasibility and safety of this specific type of ABO-incompatible lung transplant, and the impact of this practice on reducing transplant wait times among blood group O lung transplant candidates. This would represent the first prospective study of ABO-incompatible lung transplants worldwide.
Recruiting1 award N/A
Diagnostic Tools
for Lung Transplant
Demonstrate the relationship between dd-cfDNA levels and HLA antibodies in blood transplant recipient and Demonstrate the Molecular Microscope® (MMDx) Diagnostic System results in indication and protocol biopsies from lung transplants.
Recruiting1 award N/A1 criteria
More about Shaf Keshavjee, MD MSc
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Shaf Keshavjee, MD MSc has experience with
- Blood Group A2 Donor To Blood Group O Recipient Lung Transplant Surgery
Breakdown of trials Shaf Keshavjee, MD MSc has run
ABO Blood Group Incompatibility
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shaf Keshavjee, MD MSc specialize in?
Shaf Keshavjee, MD MSc focuses on Lung Transplant and ABO Blood Group Incompatibility. In particular, much of their work with Lung Transplant has involved treating patients, or patients who are undergoing treatment.
Is Shaf Keshavjee, MD MSc currently recruiting for clinical trials?
Yes, Shaf Keshavjee, MD MSc is currently recruiting for 2 clinical trials in Toronto Ontario. If you're interested in participating, you should apply.
Are there any treatments that Shaf Keshavjee, MD MSc has studied deeply?
Yes, Shaf Keshavjee, MD MSc has studied treatments such as Blood group A2 donor to blood group O recipient lung transplant surgery.
What is the best way to schedule an appointment with Shaf Keshavjee, MD MSc?
Apply for one of the trials that Shaf Keshavjee, MD MSc is conducting.
What is the office address of Shaf Keshavjee, MD MSc?
The office of Shaf Keshavjee, MD MSc is located at: Toronto General Hospital, University Health Network, Toronto, Ontario M5G 2C4 Canada. This is the address for their practice at the Toronto General Hospital, University Health Network.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.